Sharemaestro Newsreel

Zimmer Biomet (ZBH) Stock Gets Fair Value Bump After Mixed Analyst Views

Zimmer Biomet Holdings (ZBH) has seen its fair value updated by analysts, with some taking a bullish stance due to undervaluation and growth opportunities, while others remain cautious, emphasizing consistent execution and margin stabilization. The company's fair value moved from US$98.70 to approximately US$102.19, …

Globus Medical (NYSE: GMED) lifts 2026 EPS outlook on strong Q2 performance

Globus Medical (NYSE: GMED) announced strong second-quarter 2026 results, with worldwide net sales increasing by 5.9% to $789.6 million and non-GAAP diluted EPS rising 55.8% to $1.34. The company reaffirmed its 2026 revenue guidance of $3.18–$3.22 billion but raised its non-GAAP fully diluted EPS …

Earnings call transcript: AVITA Medical tops Q2 2026 estimates, shares jump

AVITA Medical (RCEL) exceeded Q2 2026 earnings estimates, reporting a narrower loss of $0.25 per share and revenue of $21.7 million, surpassing forecasts. The company raised its full-year 2026 revenue guidance to $86 million-$89 million and expects to achieve cash flow breakeven and generate …

Hyperfine Q2 Earnings Call Highlights

Key Points Interested in Hyperfine, Inc.? Here are five stocks we like better. Revenue and system sales accelerated: Second-quarter revenue rose 45% year over year to $3.9 million, with 12 systems sold versus eight a year earlier. First-half revenue increased 62% to $7.8 million, …

Earnings call transcript: Hyperfine’s Q2 2026 revenue rises 45% but misses estimates

Bio-Rad Laboratories, Inc. $BIO Shares Bought by California State Teachers Retirement System

The California State Teachers Retirement System increased its stake in Bio-Rad Laboratories (NYSE:BIO) by 22.9% in the first quarter, now owning 21,932 shares worth $6.1 million. Bio-Rad Laboratories recently reported strong Q2 adjusted earnings of $2.62 per share, exceeding analyst estimates, although revenue was …

Sanuwave Health Reports Q2 2026 Financial Results, Withdraws Full-Year Guidance on Medicare Reimbursement Uncertainty

Sanuwave Health reported Q2 2026 revenues of $9.7 million, a 3% decline from Q2 2025, resulting in a net loss of $0.7 million. The company has withdrawn its fiscal year 2026 guidance due to uncertainties surrounding Medicare reimbursement changes, particularly the proposed rule for …

CVRx Q2 Earnings Call Highlights

CVRx Inc (CVRX) reported Q2 2026 revenue of $15.7 million, up 16% year-over-year, with an 87% gross margin. However, the company lowered its full-year 2026 revenue guidance due to sales execution issues, including high sales force turnover and challenges with a major Medicare Advantage …

Alphatec Holdings, Inc. $ATEC Shares Purchased by Renaissance Technologies LLC

Renaissance Technologies LLC significantly increased its stake in Alphatec Holdings, Inc. ($ATEC) by 21.3% in the first quarter of 2026, acquiring an additional 184,969 shares and bringing its total holdings to over 1 million shares. Other institutional investors also boosted their positions in the …

Earnings call transcript: TriSalus tops Q2 revenue forecast, stock slips after hours

TriSalus Life Sciences reported Q2 revenue of $11.4 million, surpassing forecasts, driven by increased adoption of its TriNav system. Despite the revenue beat, the stock slipped after hours due to a wider adjusted EBITDA loss and higher sales and marketing expenses. The company reiterated …

Is Artivion Inc (AORT) Undervalued Despite $125.8 Million Revenue in Q2? GF Score: 82/100

Artivion Inc (AORT) reported Q2 2026 revenues of $125.8 million, an 11% year-over-year increase, exceeding analyst estimates, yet posted a net loss of $13.5 million. Despite the loss, driven partly by foreign currency revaluation and increased operating expenses, the company strengthened its product portfolio …

Is Tandem Diabetes Care Inc (TNDM) a Value Opportunity After Q2 Earnings Miss? GF Score: 66/100

Cytosorbents Corp 2Q 2026: Revenue $9.63M, EPS ($0.07) — 10-Q Summary

Cytosorbents Corp reported its second-quarter 2026 financial results, with revenue holding steady year-over-year at $9.63 million but posting a loss per share of ($0.07), a decline from the prior year's profit. The company is focusing on strategic initiatives such as channel shifts, cost reductions, …

(ECOR) Movement as an Input in Quant Signal Sets

This article from Stock Traders Daily discusses Electrocore Inc. (NASDAQ: ECOR), highlighting strong sentiment across all time horizons supporting an overweight bias. It details an exceptional 80.0:1 risk-reward setup targeting a 26.6% gain against 0.3% risk. The piece also outlines three AI-generated trading strategies …

[10-Q] CVRx, Inc. Quarterly Earnings Report

CVRx, Inc. filed its unaudited interim quarterly report (Form 10-Q) for the period ended June 30, 2026. The report details the company's financial position, including $60.0 million in debt, $64.6 million in cash, and $49.2 million in remaining ATM equity issuance capacity. The company …

Earnings call transcript: Artivion tops Q2 2026 revenue forecast as shares rise

Earnings call transcript: Establishment Labs tops revenue in Q2 2026, shares slip

Beyond Air (NASDAQ: XAIR) regains compliance, faces 1-year Nasdaq monitor

Beyond Air (XAIR) has regained compliance with Nasdaq's minimum bid price requirement following a 1-for-20 reverse stock split. The company maintained a closing bid price at or above $1.00 for 17 consecutive trading days, satisfying conditions for continued listing on The Nasdaq Capital Market. …

TransMedics Group Inc (TMDX) Stock Up 4.9% and Still Undervalued -- GF Score: 70/100

TransMedics Group Inc (TMDX) shares rose 4.9% to $80.21, but are still estimated to be 48.7% undervalued based on its GF Value™ of $156.29. The stock holds a GF Score™ of 70/100, indicating above-average performance, particularly in growth. However, significant insider selling of $0.7 …

electroCore Q2 Earnings Call Highlights

electroCore (NASDAQ:ECOR) reported a 28% year-over-year revenue increase to $9.5 million for Q2 2026, driven by strong Veterans Affairs prescription sales and direct-to-consumer Truvaga demand. The company raised its full-year outlook to over 30% growth and aims for positive adjusted EBITDA by Q3 2027 …

Establishment Labs (NASDAQ:ESTA) Releases Earnings Results

Insulet (PODD) Stock Looks Undervalued As The Market Stays Cautious

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Insulet stock has fallen sharply over the past year, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to …

TANDEM DIABETES CARE INC 2026: Revenue $254.56M, EPS ($0.31) — 10-Q Summary

Tandem Diabetes Care Inc. (TNDM) reported its 2026 quarterly results, showing revenue of $254.56 million, an increase from $240.68 million in the previous year. The company significantly reduced its net loss to ($21.17 million) from ($52.4 million) year-over-year, with diluted loss per share narrowing …

QT Imaging Holdings (QTI) grants director Bryan Timm 9,000 RSUs

QT Imaging Holdings, Inc. director Bryan Timm was granted 9,000 restricted stock units (RSUs) on August 4, 2026. The RSUs, awarded at $0.0000 per share, will vest in installments, with one-third vesting on August 15, 2027, and the remainder vesting quarterly until fully vested …

AVITA Medical Inc reports results for the quarter ended June 30 - Earnings Summary

AVITA Medical Inc has released its earnings summary for the quarter that ended on June 30. The full article, available via Reuters on TradingView, provides detailed financial results for the period.

Earnings Preview: Neuronetics to Report Financial Results Pre-market on August 11

Neuronetics is scheduled to release its financial results pre-market on August 11. Analysts are anticipating an earnings per share (EPS) of -$0.12, with revenue projected to be around $15.54 million. Investors will be closely watching these figures for insights into the company's performance.

Nano-X Imaging Raises $8 Million in Registered Direct Offering to Fund Working Capital and Corporate Initiatives

Nano-X Imaging Ltd. (NASDAQ: NNOX) has secured an $8 million registered direct offering with a long-term institutional investor. The financing, involving the sale of 8 million ordinary shares or prefunded warrants and accompanying warrants, aims to provide working capital and support the company's corporate …

Earnings call transcript: iRhythm tops revenue view in Q2 2026 and stock rises

iRhythm Technologies (IRTC) reported strong Q2 2026 results, exceeding revenue forecasts and demonstrating significant margin expansion, leading to a stock increase. The company announced the acquisition of VitalConnect, which is expected to expand its cardiac monitoring offerings and accelerate its entry into new markets …

Earnings call transcript: Delcath jumps on Q2 2026 revenue beat and raised outlook

Delcath Systems reported strong Q2 2026 results, exceeding revenue forecasts with $29.1 million, driven by demand for its HEPZATO KIT for metastatic uveal melanoma. The company raised its full-year 2026 revenue guidance to $104 million-$108 million and saw its shares jump in premarket trading. …

Globus Medical (GMED) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2026, Globus Medical (GMED) reported revenue of $789.61 million, up 5.9% over the same period last year. EPS came in at $1.34, compared to $0.86 in the year-ago quarter. The reported revenue represents a surprise of +0.35% over the …

Hyperfine, Inc. (HYPR) Reports Q2 Loss, Lags Revenue Estimates

Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates

Inogen (INGN) reported a Q2 loss of $0.14 per share, which was better than the Zacks Consensus Estimate of a $0.17 loss, and also surpassed revenue estimates with $95.08 million. Despite underperforming the S&P 500 year-to-date, the company's stock currently holds a Zacks Rank …

AHCO SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving AdaptHealth Corp.

SueWallSt, powered by Levi & Korsinsky LLP, has initiated an investigation into AdaptHealth Corp. (NASDAQ: AHCO) after the company significantly lowered its full-year 2026 revenue and adjusted EBITDA guidance, causing a stock drop of up to 26%. The investigation focuses on whether AdaptHealth made …

Profound Medical Reports Second Quarter 2026 Financial Results

Profound Medical Corp. announced strong second-quarter 2026 financial results, with a 16% decline in operating expenses and a 39% improvement in net loss. The company reiterated its full-year 2026 revenue guidance of $25.0 million despite a temporary logistics issue that shifted $3.1 million in …

Earnings Flash (AORT) Artivion, Inc. Posts Q2 Adjusted EPS $0.13 per Share, Vs. FactSet Est of $0.10

Artivion, Inc. (AORT) announced its Q2 adjusted EPS of $0.13 per share, surpassing the FactSet estimate of $0.10. This indicates a stronger financial performance than anticipated by analysts.

STERIS plc (Ireland) Stock 12‑Month Price Target Cut to $260.67, Implies 12% Upside

The average 12-month price target for STERIS plc (Ireland) stock has been lowered from $265.57 to $260.67 by 6 analysts, suggesting a potential 12% upside from its Aug. 5 closing price. Despite the reduction, the consensus rating from 11 analysts remains a "Buy," with …